Torin-1 is widely used in biomedical research as a potent and selective inhibitor of mTOR (mechanistic target of rapamycin) kinase. It is particularly valuable in studying the mTOR signaling pathway, which plays a critical role in cell growth, proliferation, and survival. Researchers utilize Torin-1 to investigate the effects of mTOR inhibition in various cellular processes, including autophagy, metabolism, and cancer biology. Its ability to inhibit both mTORC1 and mTORC2 complexes makes it a powerful tool for understanding the complex regulatory mechanisms of mTOR in normal and diseased states. Additionally, Torin-1 is employed in preclinical studies to explore its potential therapeutic applications in cancer treatment, as mTOR signaling is often dysregulated in tumors. It also aids in studying the role of mTOR in aging and neurodegenerative diseases, providing insights into potential therapeutic strategies.